FDA approves bladder cancer treatment by Culver City company
Los Angeles Times -

The Food and Drug Administration on Monday approved a new treatment for a type of bladder cancer. The treatment, which will be sold under the brand name Anktiva, is intended for some patients suffering from certain types of non-muscle invasive bladder cancer, according to an FDA statement announcing the approval. News of the FDA action was first reported by Reuters, which said, "The therapy works by activating types of disease fighting white blood cells called natural killer (NK) cells and...

In related news